US expects to approve UK-backed AstraZeneca-Oxford vaccine in April

The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official says — more than three months after Britain’s green light on Monday.

Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, does not question Britain’s move but tells reporters that US trials will be complete for approval “sometime in early April.”

This photo issued by the University of Oxford shows a vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (John Cairns/University of Oxford via AP)

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.